The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

StocksMedium•27 March 2026•

1 min read

Raymond James Upgrades Teleflex to Outperform with $128 Price Target

Key Facts

1Raymond James Financial upgraded Teleflex from a 'market perform' to an 'outperform' rating.

2A price target of $128.00 was set, implying a 15.86% potential upside.

3The upgrade comes despite a recent earnings and revenue miss, supported by the company's 2026 guidance.

Raymond James Financial has upgraded its rating for medical technology firm Teleflex (NYSE: TFX) from "Market Perform" to "Outperform." The financial firm established a new price target of $128.00 per share, representing a potential upside of approximately 15.86% from current levels. This upgrade follows a period where the company missed analyst expectations for both earnings and revenue in its latest quarterly report. However, analysts highlighted the company's 2026 financial guidance as a key driver for the more optimistic long-term outlook. The upgrade suggests that the future growth prospects for TFX outweigh recent short-term financial disappointments. Institutional investors often view such upgrades from reputable firms as a significant positive catalyst for individual stock performance.

Create Free Account

Sources: